Il team Surus Biotech sta sviluppando un nuovo sistema diagnostico e prognostico low cost per i miRNA, una nuova classe di marker tumorali.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free